Nextplat Corp (NXPL) Stock Price & Analysis
Nextplat Corp (NXPL) fell 0.59% to USD 5.87 as of July 25, 2026 at 19:05 UTC, according to Nexqual real-time market data.
NXPL last closed at USD 5.91; the session ranged USD 5.87–6.1 on volume of 5,712 shares. Market capitalization is $15.90M, with a 52-week range of USD 3.4–11.1 (NCM). Source: Nexqual, July 25, 2026 at 19:05 UTC.
Key Statistics (as of July 25, 2026 at 19:05 UTC)
| Price | USD 5.87 |
|---|---|
| Change | ▼ 0.59% (down) |
| Previous Close | USD 5.91 |
| Open | USD 6.02 |
| Day Range | USD 5.87 – 6.1 |
| 52-Week Range | USD 3.4 – 11.1 |
| Volume | 5,712 shares |
| Market Cap | $15.90M |
| Exchange | NCM |
Technical Analysis (NXPL)
Nexqual's technical model rates NXPL "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 19:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.65 (neutral) |
| vs SMA50 | Below (USD 6.45) |
| MACD | -0.16 (negative) |
Analyst Ratings (NXPL)
Wall Street analysts rate NXPL "Strong Buy" based on 1 analysts, with a mean price target of USD 12 (range USD 12–12), per Nexqual as of July 25, 2026 at 19:05 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 12 |
| High Target | USD 12 |
| Low Target | USD 12 |
| Buy / Hold / Sell | 1 / 0 / 0 |
Earnings (NXPL)
| EPS Estimate | USD -0.21 |
|---|---|
| Revenue Estimate | $11.00M |
Source: Nexqual, July 25, 2026 at 19:05 UTC.
Financials & Fundamentals (NXPL)
| Total Revenue | $50.25M |
|---|---|
| Revenue Growth (YoY) | -29.20% |
| Gross Margin | +22.79% |
| Operating Margin | -11.19% |
| Profit Margin | -19.18% |
| ROE | -45.94% |
| Debt / Equity | 10.81 |
| Current Ratio | 2.56 |
| Total Cash | $11.01M |
| Total Debt | $1.79M |
| Free Cash Flow | $-1.82M |
Source: Nexqual, July 25, 2026 at 19:05 UTC.
Financial Health Score (NXPL)
Nexqual rates Nextplat Corp's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 19:05 UTC.
| Growth | Critical — Revenue -29% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $11M cash vs $2M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$7M |
| Efficiency | Critical — ROE -46%, ROA -15.6% |
Ownership (NXPL)
| Insider Ownership | +44.88% |
|---|---|
| Institutional Ownership | +3.86% |
| Shares Outstanding | 2.71M |
| Float | 1.24M |
| Short % of Float | +0.33% |
Source: Nexqual, July 25, 2026 at 19:05 UTC.
Leadership (NXPL)
Nextplat Corp is led by David Phipps (age 59), President, CEO of Global Operations, CEO & Director, per Nexqual as of July 25, 2026 at 19:05 UTC.
| President, CEO of Global Operations, CEO & Director | David Phipps (age 59) |
|---|---|
| Chief Financial Officer | Amanda L. Ferrio (age 37) |
| Senior Vice President Mergers, Acquisitions and Special Projects | Paul R. Thomson (age 68) |
| Vice President of Healthcare Operations | Birute Norkute (age 43) |
Major Backers & Investors (NXPL)
Notable institutional backers of Nextplat Corp include Eversource Wealth Advisors, Llc, Fidelity, Jane Street Group, LLC, according to Nexqual as of July 25, 2026 at 19:05 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Eversource Wealth Advisors, Llc | 21.44% |
| Fidelity | 1.07% |
| Jane Street Group, LLC | 0.18% |
| Renaissance Technologies | 0.15% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.42% |
| Northern Trust | 0.17% |
Source: Nexqual, July 25, 2026 at 19:05 UTC.
From Nextplat Corp's Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, Asia and Pacific, and Africa.
- It operates through two segments, e-Commerce Operations and Healthcare Operations.
- The company operates full-service retail and specialty services pharmacies that provide prescription pharmaceuticals, third-party administration, risk and data management, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, medication adherence packaging, contracted pharmacy services, health practice risk management, disease testing, contracted pharmacy, and vaccinations services, as well as supplies prescription medications.
- In addition, the company provides value-added services, such as prior authorization assistance, same-day home-medication delivery, on-site provider consultation services, primary care reporting and analytics, and customized packaging solutions.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HTCR | Heartcore Enterprises, Inc. | USD 2.18 | ▼ 11.54% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
| IDAI | T Stamp Inc. | USD 1.9 | ▼ 13.64% |
| MLEC | Moolec Science SA | USD 7.2 | ▼ 2.77% |
| SVRE | SaverOne 2014 Ltd. | USD 3.56 | ▲ 5.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 19:05 UTC. This page is informational and not investment advice.